Off Madison Ave built an Arizona agency around a deceptively hard question: what do you need a person to do next? Twenty-seven years, five acquisitions and one AI travel planner later, the question still runs the place.
Two Stanford classmates spent two decades building a debt company most people never heard of. Then they renamed it Achieve, wired it to AI, and bet 2 million struggling households on one idea: do the customer's math first.
GT Medical Technologies is a Tempe, Arizona medical device company that developed GammaTile, an FDA-cleared bioresorbable radiation therapy implant for operable brain tumors. Founded by brain tumor specialists from the Barrow Neurological Institute, the company places collagen tiles embedded with Cesium-131 seeds directly into the tumor cavity at the time of surgery, delivering immediate, targeted radiation while sparing healthy tissue. Backed by a $100M Series E led by Viking Global Investors, GT Medical has treated more than 2,000 patients and is pursuing randomized trials to establish GammaTile as a standard of care.
Per Langoe is the CEO of GT Medical Technologies, the Tempe, Arizona company behind GammaTile, an FDA-cleared radiation therapy tile that gets sewn into the brain the same moment a tumor is removed. He arrived in February 2024 after co-founding and selling Palette Life Sciences to Teleflex for $600 million, bringing more than two decades in radiation oncology commercialization from Pharmacia, Q-Med, Galderma and Nestle Skin Health.
Solestial is a Tempe, Arizona space-solar company building ultrathin, radiation-hardened silicon photovoltaic modules for satellites and spacecraft. Spun out of Arizona State University research, the company makes flexible space-grade solar power modules that self-cure radiation damage at operating temperatures and targets the megawatt-class power demand of large satellite constellations and on-orbit infrastructure.
Margo de Naray is the Chief Executive Officer of Solestial, Inc., a Tempe, Arizona-based space solar power startup pioneering radiation-hardened, ultrathin silicon solar cells that self-cure radiation damage at low operating temperatures. Appointed CEO in May 2025 following the company's $17M Series A funding round, she brings 20 years of cross-industry leadership spanning aerospace (Astra Space), agribusiness (Cargill), and semiconductor manufacturing (Intel). Solestial's technology promises to slash the cost of spacecraft solar arrays by roughly 90% compared to incumbent III-V multijunction technology, using automated manufacturing and widely available silicon to make reliable space-grade solar power accessible at scale.